Genovis AB
Develops enzymatic tools for biopharma research and quality control of biological drugs.
GENO | ST
Overview
Corporate Details
- ISIN(s):
- SE0002485979
- LEI:
- 549300T5KGFRYR7ZST20
- Country:
- Sweden
- Address:
- Box 4, 244 21 Kävlinge
- Website:
- https://genovis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Genovis AB develops, produces, and markets a portfolio of enzymatic tools and technologies for the biopharmaceutical and research industries. The company's core offering is its proprietary 'SmartEnzymes' product line, which is used globally by scientists for the analysis, characterization, and quality control of biological drugs, such as monoclonal antibodies (mAbs). These tools are designed to facilitate and accelerate the development and manufacturing of new treatments and diagnostics by providing rapid and efficient solutions. Genovis also provides products and services supporting areas including Genomics, BioProcess, and Gene Therapy. The company's products are intended for research use.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Genovis AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Genovis AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
